| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1985PNAS...82.7560D |
| P356 | DOI | 10.1073/PNAS.82.22.7560 |
| P932 | PMC publication ID | 391372 |
| P698 | PubMed publication ID | 3865177 |
| P5875 | ResearchGate publication ID | 19297116 |
| P2093 | author name string | Davis AR | |
| Hung PP | |||
| Mason BB | |||
| Morin J | |||
| Hsiao CL | |||
| Dheer SK | |||
| Kostek B | |||
| P2860 | cites work | Spliced segments at the 5′ terminus of adenovirus 2 late mRNA | Q24561528 |
| Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose | Q24611198 | ||
| SV40-transformed simian cells support the replication of early SV40 mutants | Q28263905 | ||
| Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
| Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids | Q29618273 | ||
| Isolation and characterization of the major protein and glycoprotein of hepatitis B surface antigen | Q30415866 | ||
| In vitro transcription and translation of simian rotavirus SA11 gene products | Q33916261 | ||
| Characterization of messenger ribonucleoprotein and messenger RNA from KB cells | Q34694404 | ||
| Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange | Q34717841 | ||
| Cloning of a DNA fragment from the left-hand terminus of the adenovirus type 2 genome and its use in site-directed mutagenesis | Q35235265 | ||
| Generation of adenovirus by transfection of plasmids | Q35686623 | ||
| Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant. | Q36135138 | ||
| Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection | Q36262361 | ||
| Structural relationships between the surface antigens of ground squirrel hepatitis virus and human hepatitis B virus. | Q36508740 | ||
| Australia Antigen: Large-Scale Purification from Human Serum and Biochemical Studies of Its Proteins | Q36579854 | ||
| Effect of adenovirus on metabolism of specific host mRNAs: transport control and specific translational discrimination | Q36981533 | ||
| Biophysical properties of Australia antigen | Q37137809 | ||
| Polypeptides of hepatitis B virus surface antigen produced by a hepatoma cell line | Q37601633 | ||
| Identification of the components necessary for adenovirus translational control and their utilization in cDNA expression vectors | Q37676332 | ||
| Expression of adenoviral genetic information in productively infected cells | Q40130066 | ||
| Infection of eucaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA | Q40139878 | ||
| Nucleotide sequence analysis of the leader segments in a cloned copy of adenovirus 2 fiber mRNA. | Q41674431 | ||
| Biology of hepatitis B virus. | Q45801993 | ||
| Translational control of SV40 T antigen expressed from the adenovirus late promoter | Q64380954 | ||
| Construction of an adenovirus-SV40 recombinant producing SV40 T antigen from an adenovirus late promoter | Q64381571 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis B | Q6853 |
| Adenoviridae | Q193447 | ||
| P304 | page(s) | 7560-7564 | |
| P577 | publication date | 1985-11-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Expression of hepatitis B surface antigen with a recombinant adenovirus | |
| P478 | volume | 82 |
| Q64379622 | A new hamster model for adenoviral vaccination |
| Q39594077 | A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice. |
| Q43842247 | Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer |
| Q36179657 | Adenoviral vectors: development and application |
| Q35228887 | Adenovirus-Based Expression Vectors and Recombinant Vaccines |
| Q37164192 | Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model |
| Q40456070 | Adenovirus-mediated gene transfer into striated muscles. |
| Q35898573 | An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge |
| Q41704828 | Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector |
| Q36685348 | Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutant |
| Q28140401 | Development of a preventive vaccine for Ebola virus infection in primates |
| Q37949279 | Development of new cell lines for animal cell biotechnology |
| Q36826782 | Distinctive properties of the hepatitis B virus envelope proteins |
| Q36866698 | Efficient transcription, not translation, is dependent on adenovirus tripartite leader sequences at late times of infection |
| Q40429250 | Establishment of a foreign antigen secretion system in mycobacteria |
| Q64378362 | Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs |
| Q36791418 | Expression and characterization of hepatitis B virus surface antigen polypeptides in insect cells with a baculovirus expression system |
| Q40131681 | Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences |
| Q36919535 | Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity |
| Q41117008 | Function and immunogenicity of human parainfluenza virus 3 glycoproteins expressed by recombinant adenoviruses |
| Q37844073 | Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigen |
| Q40130193 | High-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system |
| Q34301871 | Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus |
| Q41336651 | Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently |
| Q40417989 | In vivo identification of sequence elements required for normal function of the adenovirus major late transcriptional control region |
| Q45866700 | Methods for construction of adenovirus vectors |
| Q37742938 | Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins |
| Q34746476 | Oral adenoviral-based vaccines: historical perspective and future opportunity |
| Q34636530 | Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters |
| Q59070708 | Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigen |
| Q42945384 | The Gordon Wilson Lecture: viruses and human disease. |
| Q36055639 | The adenovirus tripartite leader sequence can alter nuclear and cytoplasmic metabolism of a non-adenovirus mRNA within infected cells |
| Q39520194 | The pre-S region of hepadnavirus envelope proteins |
| Q40308605 | The tripartite leader sequence is required for ectopic expression of HAdV-B and HAdV-E E3 CR1 genes |
Search more.